DongKook Life Science

Established in 2017 and headquartered in Seoul, South Korea, DK Life Science Co., Ltd. operates as a pharmaceutical enterprise focused on the creation and commercialization of diagnostic pharmaceuticals and medical instruments. The company extends its reach to markets across South Korea, the European Union, Japan, and other global territories. Its product portfolio encompasses a variety of items, including active pharmaceutical ingredients (APIs), injectable medications, personal blood glucose monitoring systems, mobile computed tomography (CT) devices, and ultrasonic equipment.